A systematic review, meta-analysis and GRADE assessment of the evidence on complete mesocolic excision for right-sided colon cancer with SAGES and ESCP participation
- PMID: 40325243
- DOI: 10.1007/s00464-025-11749-7
A systematic review, meta-analysis and GRADE assessment of the evidence on complete mesocolic excision for right-sided colon cancer with SAGES and ESCP participation
Abstract
Background: Complete mesocolic excision (CME) is a surgical approach for right-sided colon cancer, involving the resection of the primary tumour along with an intact mesocolon, central vascular ligation, and exposure of the superior mesenteric vein. It has been postulated to improve oncologic outcomes such as disease-free survival and reduce local recurrence compared to standard right colectomy. However, the clinical benefits are still debated.
Objective: This systematic review and meta-analysis, sponsored by the European Association for Endoscopic Surgery, aims to compare the oncologic outcomes of CME with standard right colectomy for right-sided colon cancer, with the ultimate objective to inform clinical practice recommendations.
Methods: We followed the PRISMA 2020 reporting standards. A comprehensive literature search was conducted to identify relevant studies published from 2008 onwards, focusing on randomised trials and matched cohort studies comparing CME with standard right hemicolectomy. The GRADE methodology was used to assess the certainty of evidence, and minimal important differences were calculated to inform clinical relevance.
Results: Thirteen studies, amongst which three randomised trials, were included. No difference was found between CME and standard colectomy in terms of 30-day mortality, major peri-operative morbidity, or major blood loss. However, patients who underwent CME showed improved overall survival (HR = 0.67, 95%CI [0.48 - 0.93], low certainty of evidence) and disease-free survival (HR = 0.78, 95% CI [0.63 - 0.96], low certainty of evidence) compared to those who underwent standard colectomy, though certainty of the evidence was low due to the high risk of bias in the observational studies.
Conclusion: Complete mesocolic excision may offer survival benefits over standard right colectomy for right-sided colon cancer. However, the evidence remains of low certainty, mainly due to the predominance of observational data with significant risk of bias. Future high-quality randomized trials are needed to confirm these findings and standardize surgical techniques to reduce heterogeneity and improve clinical outcomes.
Keywords: CME; Colon cancer; Complete mesocolic excision; EAES; Guidelines.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Disclosures: The authors declare no direct conflicts of interest related to this work. Indirect conflicts of external advisors were documented and managed as per Guidelines International Network Standards. Detailed conflict of interest statements of all contributors can be found online: https://osf.io/nfkwe/?view_only=f5e504b08325402e98f1480877795f53 . Alexander A. Tzanis, Francesco Maria Carrano, Konstantinos Perivoliotis, Sunjay Kumar, Christos Christogiannis, Dimitris Mavridis, Bright Huo, Nicole Bouvy, Niki Christou, Suzanne Dore, Audrius Dulskas, Christos Kontovounisios, Tim Lubbers, Francesco Palazzo, Philip Quirke, Dimitra Repana, Monica Terlizzo, Bethany Slater, Ivan D. Florez, Monica Ortenzi, Tan Arulampalam and Stavros A. Antoniou declare no direct conflicts of interest related to this work. Indirect conflicts of external advisors were documented and managed as per Guidelines International Network Standards. Detailed conflict of interest statements of all contributors can be found in the online appendix [40]. Ethical approval: Not applicable. Informed consent: Not applicable.
References
-
- Tejedor P, Francis N, Jayne D, Hohenberger W, Khan J (2022) Consensus statements on complete mesocolic excision for right-sided colon cancer-technical steps and training implications. Surg Endosc 36(8):5595–5601. https://doi.org/10.1007/S00464-021-08395-0 - DOI - PubMed - PMC
-
- Wang C, Gao Z, Shen Z et al (2022) Five-year prognosis of complete mesocolic excision in patients with colon cancer: a prospective, nonrandomized, double-blind controlled trial. J Am Coll Surg 235(4):666–676. https://doi.org/10.1097/XCS.0000000000000282 - DOI - PubMed
-
- Kong JC, Prabhakaran S, Choy KT, Larach JT, Heriot A, Warrier SK (2021) Oncological reasons for performing a complete mesocolic excision: a systematic review and meta-analysis. ANZ J Surg 91(1–2):124–131. https://doi.org/10.1111/ANS.16518 - DOI - PubMed
-
- Sica GS, Vinci D, Siragusa L et al (2023) Definition and reporting of lymphadenectomy and complete mesocolic excision for radical right colectomy: a systematic review. Surg Endosc 37(2):846–861. https://doi.org/10.1007/S00464-022-09548-5 - DOI - PubMed
-
- Antoniou SA, Carrano FM, Tzanis AA et al (2025) Complete mesocolic excision for right-sided colon cancer: EAES rapid guideline – with SAGES and ESCP participation. Surg Endosc. 10(4):425
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources